josé luis pires sars-cov-2 report 7 august 2020 · 8/7/2020 · new cases vs 7-day average ......
TRANSCRIPT
7 August 2020SARS-Cov-2 ReportJosé Luis Pires
Confidential Hovione © 2020August 2020 2
SARS-Cov-2
➢ Confirmed cases by Country
➢ Deaths by Country
➢ Total confirmed Covid-19 cases and deaths per million people
➢ Daily new confirmed Covid-19 cases and deaths per million people
➢ New cases vs 7-day average
➢ Portugal
▪ Cases, Deaths and Projections
➢ Ireland
▪ Cases, Deaths and Projections
➢ New Jersey/US
▪ Cases, Deaths and Projections
➢ Recent News
Contents
Confidential Hovione © 2020August 2020 3
Coronavirus (SARS-CoV-2 / Covid-19) – Confirmed cases by countryNote: Selected Countries, sorted by # of cases
1,9322,1332,1942,2233,3454,6215,1235,4047,0737,5329,0389,46814,51914,58620,27221,69626,37229,64436,10845,00652,06154,79757,46572,01680,05481,96788,460120,387122,754
215,224228,195231,310237,265249,204
309,796309,855
875,3782,027,074
2,912,2124,883,657
0 1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 6,000,000
IcelandEstonia
LithuaniaSloveniaThailandHungaryGreeceCroatia
Luxembo…Finland
MalaysiaNorway
KoreaDenmarkAustralia
AustriaIreland
MoroccoSwitzerland
JapanPortugal
SingaporeNetherlands
BelgiumIsrael
SwedenChina
CanadaPhilippines
GermanyArgentina
FranceTurkey
ItalyUK
SpainRussia
IndiaBrazil
US
Last Updated at 7 August 2020, 9:34 AM
by the Center for Systems Science and Engineering
at Johns Hopkins University
Sourc
e:
htt
ps:/
/gis
anddata
.maps.a
rcgis
.com
/apps/o
psdashboard
/in
dex.h
tml#
/bda759474
0fd
40
29
94
23
46
7b
48
e9
ecf6
7 August 2020 19 June 202026 June 20203 July 202010 July 2020
In 6 weeks the number of cases doubled
17 July 202024 July 202031 July 2020
Confidential Hovione © 2020August 2020 4
Coronavirus (SARS-CoV-2 / Covid-19) – Deaths by CountryNote: Selected Countries, sorted by # of cases
160,104
98,493
41,585
14,698
28,500
46,498
35,187
5,798
30,308
4,2519,188
2,1689,013
4,6805,766576
9,8616,173
27 1,7431,0351,9854491,768719 266 617 303 256 125 331 119 155 210 602 58 125 81 63 100
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
180,000
Source: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Last Updated at 7 August 2020, 9:34 AM
by the Center for Systems Science and Engineering
at Johns Hopkins University
Confidential Hovione © 2020August 2020 5
Total confirmed Covid-19 cases per million people
Confidential Hovione © 2020August 2020 6
Daily new confirmed Covid-19 cases per million people
Confidential Hovione © 2020August 2020 7
Total confirmed Covid-19 deaths per million people
Confidential Hovione © 2020August 2020 8
Daily new confirmed Covid-19 deaths per million people
Confidential Hovione © 2020August 2020 9
New
cases v
s
7-d
ay a
vera
ge
Country/CityTotal
cases
Total
deaths
New daily cases:
reported on 6 August
New daily cases:
7-day avg
New cases vs
7-day average
6 August 20202
C
o
l
New cases vs
7-day average
30 July 202022
C
o
l
New cases vs
7-day average
23 July 202022
C
ol
u
New cases vs
7-day average
16 July 202022
C
ol
u
New cases vs
7-day average
9 July 202022
C
o
l
New cases vs
7-day average
2 July 202022
C
o
l
New cases vs
7-day average
25 June 202022
C
o
l
New cases vs
7-day average
18 June 202022
C
o
l
New cases vs
7-day average
11 June 202022
C
o
l
New cases vs
7-day average
4 June 202022
C
o
l
New cases vs
7-day average
28 May 2020
Loures 2,358 11 12 Down Down Down Down Down Down Down Up Down Up UpLisbon 4,562 22 24 Down Down Down Down Down Down Down Up Up Up Up
Lisbon and Tagus V. 26,720 608 147 112 Up Up Down Down Up Up Down Up Down Up UpLTV vs PT 69% 65% Up Down Down Up Down Up Down Down Up Up Up
New Jersey 183,701 374 390 Down Down Up Down Down Up Up Up Up Down UpCork 26,372 2 1 Up Down Down Down Up Down Down Down Down Down Down
Argentina 228,195 4,251 6,792 5,740 Up Up Up Up Up Down Up Up Up Up Down
Australia 20,272 266 715 552 Up Down Up Up Down Up Up Up Down Down Down
Austria 21,696 719 103 104 Down Up Up Down Up Down Down Down Up Up Down
Belgium 72,016 9,861 - - Down Down Up Up Up Up Down Down Up Down Down
Brazil 2,912,212 98,493 51,603 45,533 Up Down Up Up Up Down Up Up Up Up Down
Canada 120,387 9,013 761 400 Up Down Up Up Down Down Down Down Down Down Down
China 88,460 4,680 122 161 Down Up Up Down Up Up Down Up Up Down Down
Croatia 5,404 155 58 65 Down Down Up Up Down Down Up Up Up Up Down
Denmark 14,586 617 112 79 Up Up Up Up Down Up Up Up Down Down Up
Estonia 2,133 63 22 10 Up Up Up Down Up Down Up Down Up Up Down
Finland 7,532 331 29 14 Up Up Up Down Down Up Up Down Down Down Up
France 231,310 30,308 1,615 1,171 Up Up Up Up Up Up Down Down Down Down Down
Germany 215,224 9,188 1,045 753 Up Down Up Up Up Down Up Up Up Down Down
Greece 5,123 210 118 91 Up Up Up Down Up Up Down Up Down Up Up
Hungary 4,621 602 11 11 Up Up Down Down Down Down Up Down Down Down Down
Iceland 1,932 10 8 9 Down Up Down Up Up Up Up Up Up Up Up
India 2,027,074 41,585 56,282 54,392 Up Up Up Up Up Up Up Up Up Up Down
Ireland 26,372 1,768 50 52 Down Down Down Down Down Down Down Down Down Up Down
Italy 249,204 35,187 384 290 Up Up Up Down Down Up Up Up Down Down Up
Japan 45,006 1,035 1,134 1316 Down Up Up Up Down Up Up Down Up Down Down
Korea 14,519 303 43 33 Up Down Up Up Down Up Down Up Up Down Up
Malaysia 9,038 125 21 10 Up Down Up Down Down Down Down Down Down Up Down
Netherlands 57,465 6,173 426 394 Up Up Up Up Up Down Down Down Down Down Up
Norway 9,468 256 29 30 Down Up Up Up Up Down Up Down Down Down Up
Philippines 122,754 2,168 3,387 4356 Down Down Down Up Up Up Down Up Up Up Up
Portugal 52,061 1,743 213 163 Up Down Up Up Up Up Up Down Down Up Up
Russia 875,378 14,698 5,267 5,342 Down Down Down Down Down Up Down Up Up Down Down
Singapore 54,797 27 908 389 Up Down Up Up Down Up Down Up Up Up Up
Spain 309,855 28,500 2,953 2,649 Up Up Down Up Down Down Down Down Up Down Down
Sweden 81,967 5,766 359 251 Up Up Up Up Down Up Up Down Up Up Up
Switzerland 36,108 1,985 181 161 Up Up Up Up Up Down Up Down Up Up Down
Thailand 3,345 58 2 4 Down Up Up Down Up Up Down Up Down Up Up
Turkey 237,265 5,798 1,178 1,027 Up Up Down Down Down Down Up Up Down Down Up
UK 309,796 46,498 891 818 Up Up Down Down Up Down Down Down Down Up Down
US 4,883,657 160,104 49,629 57,868 Down Down Up Down Down Up Up Up Down Up Up
Confidential Hovione © 2020August 2020 10
Daily deaths of
patients diagnosed
with coronavirus
(7-day average)
So
urc
e: h
ttp
s:/
/ww
w.f
t.co
m/c
on
ten
t/a
26fb
f7e
-48f8
-11
ea-a
eb3
-955
839
e06
441
Portugal
Confidential Hovione © 2020August 2020 12
Coronavirus (SARS-CoV-2 / COVID 19) – Portugal - Total cases by day
2 4 6 9132130394159781121692453314486427851,0201,2801,6002,0602,3622,9953,5444,268
5,1705,9626,408
7,4438,251
9,0349,88610,524
11,27811,73012,452
13,14113,956
15,47215,98716,58516,93417,44818,09118,84119,02219,68520,20620,86321,37921,98222,35322,79723,39223,86424,02724,32224,50525,05625,35125,19025,28225,52425,70226,18226,71527,26827,40627,58127,67927,91328,13228,31928,58328,81029,03629,20929,43229,66029,912
30,200
30,47130,62330,78831,00731,29231,596
31,946
32,20332,50032,70032,89533,26133,592
33,969
34,35134,69334,88535,30635,60035,910
36,18036,46336,69037,03637,33637,67238,089
38,46438,84139,13339,39239,73740,10440,415
40,86641,18941,64641,91242,14142,454
42,78243,15643,56943,89744,12944,41644,859
45,27745,87946,22146,51246,81847,05147,426
47,76548,07748,39048,63648,77148,89849,150
49,37949,69249,95550,16450,29950,41050,613
50,86851,07251,31051,46351,56951,68151,848
52,061
0%
100%
50%50%
44%
62%
43%
30%
5%
44%
32%
44%
51%
45%
35%35%
43%
22%
30%25%
25%29%
15%
27%
18%20%21%
15%
7%
16%
11%9%9%6%7%
4%6%6%6%
11%
3%4%2%3%4%4%1%
3%3%3%2%3%2%2%3%2%1%1%1%2%1%0%1%1%2%2%2%1%1%0%1%1%1%1%1%1%1%1%1%1%1%1%0%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%0%1%1%1%1%1%0%0%1%0%1%1%0%0%0%0%1%0%0%0%0%0%0%0%
0%
20%
40%
60%
80%
100%
120%
0
10000
20000
30000
40000
50000
60000
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
# of cases % increase
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 13
Coronavirus (SARS-CoV-2 / COVID 19) – Portugal - Confirmed cases by day
222348992181934577686
117
194143
235260
320
460
302
633
549
724
902
792
446
1035
808783
852
638
754
452
712699
815
1516
515
598
349
514
643
750
181
663
521
657
516
603
371
444
595
472
163
295
183
540
306
0
92
242
178
480533553
138175
98
234219187
264227226
173223228
252288271
152165219
285304350
257297
200195
366331
377382342
192
421
294310270283
227
346300
336
417375377
292259
345367
311
451
323
457
266229
313328374
413
328
232
287
443418
602
342291306
233
375339
312313
246
135127
252229
313263
209
135111
203255
204238
153106112
167213
0
200
400
600
800
1000
1200
1400
1600
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
10 July – 602 cases
The biggest increase since April 22
Confidential Hovione © 2020August 2020 14
Coronavirus (SARS-CoV-2 / COVID 19) – Portugal – Hospital: Stable vs ICU
00 09132130384057
107107114139139
206
8989126
156169201203
276
191
354
418
486
571
627
726
10421058107510841099
11801211
117311791175117711871227
1200
1302128412531243
12081172
1146
10951068
10401005995
936980968
892855856
813818838
874842
815797805
709692680673657649
628629609608
576550536531513510512529514
474471432428445
421414398366
394417415
440428
419431423435416422
422
407424441429436
457
442458
489491503510495489504513511512
487
471459462467472478
476
447452439454439439
431
420410403414402403403
381375378390401384369
00 000 000 000 010918172020263541474861617189
136164
188230240245251267270271
245241226233228188
218208229222228224215213207204188186182176172169172154150144143134136135127120112112113103108112115108105101939284807872716665666364645856585857585565707073
77
737371696767
706972727367
677075717379
77727373747674
73
666864636968
72676561616259
59
52504845414342
41404142444142
0
200
400
600
800
1000
1200
1400
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
2.j
un
4.j
un
6.j
un
8.j
un
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
2.j
ul
4.j
ul
6.j
ul
8.j
ul
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Hospital Stable Hospital ICU
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 15
Coronavirus (SARS-CoV-2 / COVID 19) – Portugal – Deaths vs Recoveries
0000000000000011236121423334360761001191401601872092462662953113453804094354705045355675996296576877147357627858208548809039289489739891007102310431063107410891105111411261135114411631175118411901203121812311247126312771289
1302
131613301342135613691383
1396141014241436144714551465
1474147914851492149715041505
1512
151715201522152315241527
1528
15301534154015431549
1555
15611564156815761579
1587
159816051614162016291631
1644
164616541660166216681676
1679
168216841689169116971702
1705
171217161717171917221725
1727
173517371738173817391740
1743
000000000011123333555142222434343434343436868757514018419620523326627727734738349351961061061091711461201122812771329135713891470151916471671168917121743207622582422249925492549301331823198332838224636
643064316452645275907705
175491782218096183491863718911
19186194091955219869200792032320526
20807
209952115621339217422200222200
22438
226692285223212235802401024477
24906
2537625548258292608326382
26633
2686427066272052750527798
28097
284242877229017291662944529714
30049
303503065530907310653155032110
32476327903315333369335473376933999
34369
34687350103521735375356263587536140
36483367833698437111373183756537840
0
5000
10000
15000
20000
25000
30000
35000
40000
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
2.j
un
4.j
un
6.j
un
8.j
un
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
2.j
ul
4.j
ul
6.j
ul
8.j
ul
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Total Confirmed Deaths Total Confirmed Recoveries
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 16
Coronavirus
(SARS-CoV-2 / COVID 19)
Portugal
6 August 2020
Confidential Hovione © 2020August 2020 17
Coronavirus (SARS-CoV-2 / COVID 19) – Loures - Total cases by day
2428282857647284101109117126130131134138158179191196201212221231240251257260
292292301303304315315315369386393400408410420
453464464497505507
536559576591604612642656678
715
771802819828
863894
934
9821,009
1,0431,0661,0891,1141,147
1,1721,191
1,2091,2361,288
1,3311,352
1,383
1,4241,4361,4471,4921,512
1,548
1,5761,6041,623
1,6541,6801,7071,720
1,7451,756
1,7911,8121,8271,856
1,8721,8871,9101,9101,9101,9101,910
1,910
1,9101,9101,9101,910
2,0882,088
2,0882,0882,0882,088
2,1972,1972,197
2,1972,1972,1972,197
2,2842,2842,284
2,284
2,2842,2842,284
2,3582,3582,358
2,358
17%
0%0%
104%
12%13%17%
20%
8%7%8%
3%1%2%3%
14%13%7%3%
3%5%4%5%4%5%
2%1%
12%
0%3%
1%0%4%
0%0%
17%
5%2%2%2%0%
2%
8%
2%0%
7%
2%0%
6%4%3%3%2%1%5%
2%3%5%
8%4%
2%1%4%4%4%5%
3%3%2%2%2%3%2%2%2%2%4%3%2%2%3%
1%1%3%1%2%2%2%1%2%2%2%1%1%1%2%1%1%2%1%1%1%0%0%0%0%0%0%0%0%0%
9%
0%0%0%0%0%
5%
0%0%0%0%0%0%4%
0%0%0%0%0%0%3%
0%0%0%
0%
20%
40%
60%
80%
100%
120%
0
500
1000
1500
2000
2500
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
# of cases % increase
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 18
Coronavirus (SARS-CoV-2 / COVID 19) – Loures - Confirmed cases by day
400
29
7812
17
8894134
2021
1255
1191091163
32
0
921
11
00
54
17
7782
10
33
11
0
33
82
2923
1715138
30
14
22
37
56
31
17
9
3531
40
48
2734
232325
33
251918
27
52
43
21
31
41
1211
45
20
36
2828
19
312627
13
25
11
35
2115
29
1615
23
000000000
178
00000
109
000000
87
000000
74
000
0
20
40
60
80
100
120
140
160
180
200
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 19
Coronavirus (SARS-CoV-2 / COVID 19) – Lisbon - Total cases by day
175187284284
366
5946335465946346546816997547737978518678909059469629961,0201,0331,0381,060
1,1451,1691,2661,271
1,3461,4061,4131,4131,4471,4651,496
1,5671,5671,5671,5791,6271,6681,7001,7241,7351,7371,7911,8111,8351,8711,9191,9381,9622,0182,0462,0762,107
2,1462,1772,1822,2062,2542,2902,324
2,365
2,4002,4092,4472,4862,5362,555
2,595
2,6142,6402,7002,7512,7892,803
2,852
2,8522,8802,9222,9402,9793,037
3,096
3,1353,1503,1913,2383,2773,335
3,3473,4233,4533,5023,5443,573
3,5843,6453,6453,6453,6453,6453,645
3,645
3,6453,6453,645
4,0844,0844,084
4,0844,0844,084
4,2404,2404,2404,240
4,2404,2404,240
4,4084,4084,408
4,4084,4084,4084,408
4,5624,5624,562
4,562
7%
52%
0%
29%
62%
7%
0%
9%7%
3%4%3%
8%
3%3%
7%
2%
3%2%5%
2%4%
2%1%0%
2%
8%
2%
8%
0%
6%4%
0%0%2%
1%2%
5%
0%0%1%3%3%2%1%1%0%
3%1%1%2%3%
1%1%3%
1%1%1%2%1%0%1%
2%2%1%2%1%0%
2%2%2%1%2%1%1%
2%2%1%1%2%
0%1%1%1%1%2%2%1%0%1%1%1%2%0%
2%1%1%1%1%0%
2%0%0%0%0%0%0%0%0%0%
12%
0%0%0%0%0%
4%
0%0%0%0%0%0%
4%
0%0%0%0%0%0%
3%
0%0%0%
0%
10%
20%
30%
40%
50%
60%
70%
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
2.a
pr
4.a
pr
6.a
pr
8.a
pr
10
.ap
r
12
.ap
r
14
.ap
r
16
.ap
r
18
.ap
r
20
.ap
r
22
.ap
r
24
.ap
r
26
.ap
r
28
.ap
r
30
.ap
r
2.m
ay
4.m
ay
6.m
ay
8.m
ay
10
.ma
y
12
.ma
y
14
.ma
y
16
.ma
y
18
.ma
y
20
.ma
y
22
.ma
y
24
.ma
y
26
.ma
y
28
.ma
y
30
.ma
y
01
.ju
n
03
.ju
n
05
.ju
n
07
.ju
n
09
.ju
n
11
.ju
n
13
.ju
n
15
.ju
n
17
.ju
n
19
.ju
n
21
.ju
n
23
.ju
n
25
.ju
n
27
.ju
n
29
.ju
n
01
.ju
l
03
.ju
l
05
.ju
l
07
.ju
l
09
.ju
l
11
.ju
l
13
.ju
l
15
.ju
l
17
.ju
l
19
.ju
l
21
.ju
l
23
.ju
l
25
.ju
l
27
.ju
l
29
.ju
l
31
.ju
2.a
ug
4.a
ug
6.a
ug
# of cases % increase
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 20
Coronavirus (SARS-CoV-2 / COVID 19) – Lisbon - Confirmed cases by day
12
97
0
82
228
39414840
202718
55
1924
54
162315
41
1634
2413
522
85
24
97
5
7560
70
3418
31
71
0012
484132
2411
2
54
202436
48
1924
56
28303139
31
524
4836344135
93839
50
19
40
1926
6051
38
14
49
0
2842
18
395859
39
15
414739
58
12
76
304942
2911
61
000000000
439
00000
156
0000 0
168
000000
154
000
0
50
100
150
200
250
300
350
400
450
500
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
2.a
pr
4.a
pr
6.a
pr
8.a
pr
10
.ap
r
12
.ap
r
14
.ap
r
16
.ap
r
18
.ap
r
20
.ap
r
22
.ap
r
24
.ap
r
26
.ap
r
28
.ap
r
30
.ap
r
2.m
ay
4.m
ay
6.m
ay
8.m
ay
10
.ma
y
12
.ma
y
14
.ma
y
16
.ma
y
18
.ma
y
20
.ma
y
22
.ma
y
24
.ma
y
26
.ma
y
28
.ma
y
30
.ma
y
01
.ju
n
03
.ju
n
05
.ju
n
07
.ju
n
09
.ju
n
11
.ju
n
13
.ju
n
15
.ju
n
17
.ju
n
19
.ju
n
21
.ju
n
23
.ju
n
25
.ju
n
27
.ju
n
29
.ju
n
01
.ju
l
03
.ju
l
05
.ju
l
07
.ju
l
09
.ju
l
11
.ju
l
13
.ju
l
15
.ju
l
17
.ju
l
19
.ju
l
21
.ju
l
23
.ju
l
25
.ju
l
27
.ju
l
29
.ju
l
31
.ju
2.a
ug
4.a
ug
6.a
ug
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 21
Coronavirus (SARS-CoV-2 / COVID 19) – Lisbon and Tagus Valley - Total
cases by day
1 2 3 4 5 6 910172346731161421802432783644485347378529921,0821,1101,2871,4781,5771,7991,9982,2072,3472,5132,9043,0703,1853,2243,451
3,8213,8343,8413,8963,9944,1024,2374,3024,4384,5004,7094,8965,0935,1945,2775,4355,5315,5565,5935,6955,8155,9396,0476,0476,1366,2416,6416,9357,0937,1667,2427,3167,4947,6477,7677,9518,0978,2358,3618,4908,688
8,8789,1069,2929,4239,5679,77810,055
10,320
10,64310,87411,14211,33511,49311,82812,137
12,47312,81813,07313,222
13,60813,87814,161
14,407
14,62214,82815,12815,36415,64615,971
16,255
16,53716,76216,92617,22517,52717,767
18,106
18,36118,75218,97719,16519,383
19,656
19,95620,27320,52720,72220,92921,256
21,58422,12622,38522,61122,86523,00823,296
23,57023,80624,04724,26124,36924,47024,685
24,85725,11025,29325,44825,54925,61725,763
25,93926,06726,23126,32326,38926,45726,573
26,720
100%
50%
33%
25%
20%
50%
11%
70%
35%
100%
59%59%
22%
27%
35%
14%
31%23%
19%
38%
16%16%
9%
3%
16%15%
7%
14%11%10%
6%7%
16%
6%4%
1%
7%11%
0%0%1%3%3%3%2%3%
1%5%4%4%
2%2%3%2%0%1%2%2%2%2%0%1%2%
6%4%
2%1%1%1%2%2%2%2%2%2%2%2%2%2%3%2%1%2%2%3%3%3%2%2%2%1%3%3%3%3%2%1%3%2%2%2%1%1%2%2%2%2%2%2%1%1%2%2%1%2%1%2%1%1%1%1%2%2%1%1%1%2%2%3%1%1%1%1%1%1%1%1%1%0%0%1%1%1%1%1%0%0%1%1%0%1%0%0%0%0%1%
0%
20%
40%
60%
80%
100%
120%
0
5000
10000
15000
20000
25000
30000
# of cases % increase
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 22
Coronavirus (SARS-CoV-2 / COVID 19) – Lisbon and Tagus Valley -
Confirmed cases by day
01111131762327
4326
38
63
35
868486
203
115
140
90
28
177191
99
222
199209
140
166
391
166
115
39
227
370
137
55
98108
135
65
136
62
209187
197
10183
158
96
2537
102120124
108
0
89105
400
294
158
737674
178
153
120
184
146138126129
198190
228
186
131144
211
277265
323
231
268
193
158
335
309
336345
255
149
386
270283
246
215206
300
236
282
325
284282
225
164
299302
240
339
255
391
225
188
218
273
300317
254
195207
327328
542
259
226
254
143
288274
236241
214
108101
215
172
253
183
155
101
68
146
176
128
164
92
6668
116
147
0
100
200
300
400
500
600
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 23
Coronavirus (SARS-CoV-2 / COVID 19) – % of new cases in Lisbon and Tagus
valley
111113176232743263863
35868486
203
115140
90
28
177191
99
222199209
140166
391
166115
39
227
370
13755
98108135
65
136
62
209187197
10183
158
96
2537
102120124108
0
89105
400
294
15873
7674
178153
120
184146138126129
198190228
186
131144
211
277265
323
231268
193158
335309
336345
255
149
386
270283246
215206
300
236282
325284282
225
164
299302
240
339
255
391
225188
218
273300317
254
195207
327328
542
259226
254
143
288274236241
214
108101
215172
253
183155
10168
146176
128164
926668
116147
2348992181934577686
117
194143
235260
320
460
302
633
549
724
902
792
446
1,035
808783
852
638
754
452
712699
815
1,516
515
598
349
514
643
750
181
663
521
657
516
603
371
444
595
472
163
295
183
540
306
92
242
178
480
533553
138175
98
234219187
264227226
173223228
252288271
152165
219
285304350
257297
200195
366331
377382342
192
421
294310270283
227
346300
336
417375377
292259
345367
311
451
323
457
266229
313328374
413
328
232
287
443418
602
342291306
233
375339
312313
246
135127
252229
313263
209
135111
203
255204
238
153106112
167213
50%
33%
25%
13%11%
33%
50%
39%
32%
68%
47%
57%
30%32%32%
24%
37%
32%
27%
44%
38%
22%
16%
4%
20%
24%22%21%
25%27%
16%
26%
52%
37%
16%
6%
28%24%
3%1%
16%19%
17%18%
36%
21%
12%
32%
36%33%
27%
19%
27%
20%
15%13%
56%
22%
41%
0%0%
37%
59%
83%
55%
29%
53%
43%
76%76%
70%
64%
70%
64%61%
73%
58%
87%
75%79%
69%
86%87%
96%97%
87%
92%
90%90%
97%
81%
92%93%
89%
90%
75%78%
92%92%91%
91%
76%
91%
87%
79%
84%
78%76%
75%77%
63%
87%
82%
77%75%
79%
86%85%82%
70%
83%
80%77%77%
84%
72%74%
78%
90%
76%78%
83%
61%
77%81%
76%77%
87%
80%80%
85%
75%
81%
70%
74%75%
61%
72%69%
63%
69%
60%62%61%
69% 69%
0%
20%
40%
60%
80%
100%
120%
0
200
400
600
800
1000
1200
1400
1600
4.m
ar
6.m
ar
8.m
ar
10
.mar
12
.mar
14
.mar
16
.mar
18
.mar
20
.mar
22
.mar
24
.mar
26
.mar
28
.mar
30
.mar
1.a
br
3.a
br
5.a
br
7.a
br
9.a
br
11
.abr
13
.abr
15
.abr
17
.abr
19
.abr
21
.abr
23
.abr
25
.abr
27
.abr
29
.abr
1.m
ai
3.m
ai
5.m
ai
7.m
ai
9.m
ai
11
.mai
13
.mai
15
.mai
17
.mai
19
.mai
21
.mai
23
.mai
25
.mai
27
.mai
29
.mai
31
.mai
2.jun
4.jun
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Lisbon and Tagus valley Portugal % of new cases
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 24
Covid-19 Projections Using Machine Learning – Portugal - Cases
Source: https://covid19-projections.com/portugal
Confidential Hovione © 2020August 2020 25
Covid-19 Projections Using Machine Learning – Portugal - Deaths
Source: https://covid19-projections.com/portugal
Ireland
Confidential Hovione © 2020August 2020 27
Coronavirus (SARS-CoV-2 / COVID 19) – Ireland - Total cases by day
10 361318192124344370901291692232923665576837859061,1251,3291,5641,8192,1212,4152,6152,9103,2353,4473,849
4,3734,6044,9945,3645,7096,074
6,5747,054
8,9289,655
10,64711,479
12,54713,271
13,98014,758
15,25115,652
16,04016,671
17,60718,184
18,56119,262
19,64819,87720,25320,61220,83321,17621,50621,77221,98322,24822,38522,54122,76022,99623,13523,24223,40123,827
23,95624,04824,11224,20024,25124,315
24,391
24,50624,58224,63924,69824,73524,803
24,841
24,87624,92924,99025,06225,06625,111
25,142
25,16325,18325,20125,20725,21525,231
25,238
25,25025,29525,30325,32125,33425,341
25,355
25,36825,37425,37925,38325,39125,396
25,405
25,41425,43725,43825,46225,47325,477
25,489
25,49825,50925,52725,53125,53825,542
25,565
25,58925,61125,62825,63825,67025,683
25,698
25,73025,75025,76025,76625,80225,819
25,826
25,84525,86925,88125,89225,92925,942
26,027
26,06526,10926,16226,20826,25326,303
26,372
100%
117%
38%
6%
11%14%
42%
26%
63%
29%
43%31%
32%31%
25%
52%
23%
15%15%
24%
18%18%16%17%14%
8%11%11%
7%
12%14%
5%8%7%6%6%8%7%
27%
8%10%
8%9%6%5%6%
3%3%2%4%6%3%2%4%2%1%2%2%1%2%2%1%1%1%1%1%1%1%1%0%1%2%1%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
0%
20%
40%
60%
80%
100%
120%
140%
0
5000
10000
15000
20000
25000
30000
29
.fe
v
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
# of cases % increase
Source: https://geohive.maps.arcgis.com/apps/opsdashboard/index.html#/29dc1fec79164c179d18d8e53df82e96
Confidential Hovione © 2020August 2020 28
Coronavirus (SARS-CoV-2 / COVID 19) – Ireland - Confirmed cases by day
10014751231092720
394054
6974
191
126102
121
219204
235255
302294
200
295325
212
402424
331
390370
345365
500480
553
430
527548
657629
597630
445
401388
631
936
577
377
701
386
229
376359
221
343330
266
211
265
137156
219236
139107
159
426
129
9264
88
516476
115
765759
37
734639
596677
10
47382824259919813
46
81814816132264105111123
1241161591118
424112325231711
3214213421106
3617720241211
4014
85
38455346455069
29
.fe
v
2.m
ar
4.m
ar
6.m
ar
8.m
ar
10
.ma
r
12
.ma
r
14
.ma
r
16
.ma
r
18
.ma
r
20
.ma
r
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
pr
3.a
pr
5.a
pr
7.a
pr
9.a
pr
11
.ap
r
13
.ap
r
15
.ap
r
17
.ap
r
19
.ap
r
21
.ap
r
23
.ap
r
25
.ap
r
27
.ap
r
29
.ap
r
1.m
ay
3.m
ay
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
28
.ju
n
30
.ju
n
02
.ju
l
04
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
12
.ju
l
14
.ju
l
16
.ju
l
18
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
1.a
ug
3.a
ug
5.a
ug
Source: https://geohive.maps.arcgis.com/apps/opsdashboard/index.html#/29dc1fec79164c179d18d8e53df82e96
Confidential Hovione © 2020August 2020 29
Coronavirus (SARS-CoV-2 / COVID 19) – Cork - Total cases by day
101104123133154171184
208217238255272292304
343362
421431472
503
581
648
730780
829
916945
9791,0281,0471,053
1,0771,0871,0961,1031,1101,1251,1261,1361,1461,1541,1561,1641,1751,1771,1921,1971,1991,2051,2071,2321,2341,2381,2491,256
1,3461,3521,3611,3721,3761,3861,3981,4201,4281,4381,4401,4511,4581,4641,4721,477
1,5141,5171,517
1,5211,5271,5281,5291,5291,5291,531
1,5321,5331,5331,5331,5331,5331,535
1,535
1,5351,5351,5351,5351,5351,535
1,535
1,5351,5361,5361,536
1,536
1,5401,5431,5431,543
1,545
1,5451,5461,5481,550
1,550
1,5541,5571,557
1,560
1,5601,5621,5621,5631,5631,5631,563
1,563
1,5661,5691,570
1,572
3%
18%
8%
16%
11%
8%
13%
4%
10%
7%7%
7%
4%
13%
6%
16%
2%
10%
7%
16%
12%
13%
7%6%
10%
3%4%
5%
2%
1%
2%
1%1%1%1%1%
0%
1%1%1%0%
1%1%
0%
1%
0%0%1%
0%
2%
0%0%1%
1%
7%
0%1%1%0%
1%1%2%
1%1%0%
1%0%0%1%0%
3%
0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
0
200
400
600
800
1000
1200
1400
1600
1800
22
.ma
r
24
.ma
r
26
.ma
r
28
.ma
r
30
.ma
r
1.a
br
3.a
br
5.a
br
7.a
br
9.a
br
11
.ab
r
13
.ab
r
15
.ab
r
17
.ab
r
19
.ab
r
21
.ab
r
23
.ab
r
25
.ab
r
27
.ab
r
29
.ab
r
1.m
ai
3.m
ai
5.m
ay
7.m
ay
9.m
ay
11
.ma
y
13
.ma
y
15
.ma
y
17
.ma
y
19
.ma
y
21
.ma
y
23
.ma
y
25
.ma
y
27
.ma
y
29
.ma
y
31
.ma
y
02
.ju
n
04
.ju
n
06
.ju
n
08
.ju
n
10
.ju
n
12
.ju
n
14
.ju
n
16
.ju
n
18
.ju
n
20
.ju
n
22
.ju
n
24
.ju
n
26
.ju
n
30
.ju
n
02
.ju
l
06
.ju
l
08
.ju
l
10
.ju
l
14
.ju
l
16
.ju
l
20
.ju
l
22
.ju
l
24
.ju
l
26
.ju
l
28
.ju
l
30
.ju
l
4.a
ug
6.a
ug
# of cases % increase
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 30
Coronavirus (SARS-CoV-2 / COVID 19) – Cork - Confirmed cases by day
3
19
10
21
17
13
24
9
21
171720
12
39
19
59
10
41
31
78
67
82
5049
87
29
34
49
19
6
24
10977
15
1
10108
2
811
2
15
52
6
2
25
24
11
7
90
6911
4
1012
22
810
2
11
76
85
37
30
46
11002110000
2000000000001000
4300
20122
0
430
30
2010000
3000
312
0
10
20
30
40
50
60
70
80
90
100
Source: https://covid19.min-saude.pt/ponto-de-situacao-atual-em-portugal/
Confidential Hovione © 2020August 2020 31
Covid-19 Projections Using Machine Learning – Ireland - Cases
Source: https://covid19-projections.com/ireland
Confidential Hovione © 2020August 2020 32
Covid-19 Projections Using Machine Learning – Ireland - Deaths
Source: https://covid19-projections.com/ireland
New Jersey
Confidential Hovione © 2020August 2020 34
Coronavirus (SARS-CoV-2 / COVID 19) – New Jersey - Total cases by day
1046111523295069981782674277428901,3271,9142,8443,6754,4026,8768,82511,12413,38616,63618,696
22,25525,590
29,89534,124
37,50541,090
44,41647,437
51,02754,588
58,15161,850
64,58468,82471,030
75,31778,467
81,42085,301
88,80692,387
95,86599,989102,196
105,523109,038111,188
113,856116,264118,652121,190
123,717126,744128,269130,593131,890133,635135,454137,085138,532139,945140,743141,560142,704143,905145,089146,334148,039149,013150,399
151,472152,719153,104154,154155,092155,764156,628
157,815
158,844159,608160,445160,918161,545162,068
162,530163,336163,893164,164164,497164,796165,346
165,816
166,164166,605166,881167,103167,426167,703
168,107
168,496168,834169,142169,415169,734169,892
170,196
170,584170,873171,182171,272171,667171,928
172,356
172,742173,033173,402173,611173,878174,039
174,240
174,628174,959175,298175,522175,915176,278
176,501
176,551176,814176,783176,963177,256177,645
177,887
178,345178,858179,363179,812180,295180,766
180,970
181,660182,029182,350182,614182,970183,327
183,701
50%
83%
36%
53%
26%
72%
38%
42%
82%
50%
60%
74%
20%
49%
44%
49%
29%
20%
56%
28%26%
20%
24%
12%
19%
15%17%14%
10%10%8%7%8%7%7%6%4%7%3%6%4%4%5%4%4%4%4%
2%3%3%2%2%2%2%2%2%2%1%2%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%1%0%1%1%0%1%1%1%0%1%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
-10%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
0
20000
40000
60000
80000
100000
120000
140000
160000
180000
200000
5.m
ar
7.m
ar
9.m
ar
11
.ma
r
13
.ma
r
15
.ma
r
17
.ma
r
19
.ma
r
21
.ma
r
23
.ma
r
25
.ma
r
27
.ma
r
29
.ma
r
31
.ma
r
2.a
pr
4.a
pr
6.a
pr
8.a
pr
10
.ap
r
12
.ap
r
14
.ap
r
16
.ap
r
18
.ap
r
20
.ap
r
22
.ap
r
24
.ap
r
26
.ap
r
28
.ap
r
30
.ap
r
2.m
ay
4.m
ay
6.m
ay
8.m
ay
10
.ma
y
12
.ma
y
14
.ma
y
16
.ma
y
18
.ma
y
20
.ma
y
22
.ma
y
24
.ma
y
26
.ma
y
28
.ma
y
30
.ma
y
01
.ju
n
03
.ju
n
05
.ju
n
07
.ju
n
09
.ju
n
11
.ju
n
13
.ju
n
15
.ju
n
17
.ju
n
19
.ju
n
21
.ju
n
23
.ju
n
25
.ju
n
27
.ju
n
29
.ju
n
01
.ju
l
03
.ju
l
05
.ju
l
07
.ju
l
09
.ju
l
11
.ju
l
13
.ju
l
15
.ju
l
17
.ju
l
19
.ju
l
21
.ju
l
23
.ju
l
25
.ju
l
27
.ju
l
29
.ju
l
31
.ju
2.a
ug
4.a
ug
6.a
ug
# of cases % increase
Source: https://www.nj.com/coronavirus/2020/03/see-the-spread-of-nj-coronavirus-in-charts-map-sunday-march-22-2020.html
Confidential Hovione © 2020August 2020 35
Coronavirus (SARS-CoV-2 / COVID 19) – New Jersey - Confirmed cases by
day
103254862119298089160
315148
437587
930831
727
2474
1949
22992262
3347
2196
36493489
43724229
3382
3663
3361
3088
374836273563
3733
3219
4059
2625
4391
3150
2953
3881
35053581
3478
4124
2207
3327
3515
2150
2668
2408238825382527
3027
1525
2324
1297
17451819
1631
14471413
798817
1144120111841245
1705
974
1386
1073
1247
385
1050938
672
864
11871029
764837
473627
523462
806
557
271333299
550470
348441
276222323277
404389338308273319158
304388
289309
90
395261
428386291
369209267
161201
388331339224
393363223
50
263
0
180293
389242
458513505449483471
204
690
369321264356357374
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5.m
ar
7.m
ar
9.m
ar
11
.ma
r
13
.ma
r
15
.ma
r
17
.ma
r
19
.ma
r
21
.ma
r
23
.ma
r
25
.ma
r
27
.ma
r
29
.ma
r
31
.ma
r
2.a
pr
4.a
pr
6.a
pr
8.a
pr
10
.ap
r
12
.ap
r
14
.ap
r
16
.ap
r
18
.ap
r
20
.ap
r
22
.ap
r
24
.ap
r
26
.ap
r
28
.ap
r
30
.ap
r
2.m
ay
4.m
ay
6.m
ay
8.m
ay
10
.ma
y
12
.ma
y
14
.ma
y
16
.ma
y
18
.ma
y
20
.ma
y
22
.ma
y
24
.ma
y
26
.ma
y
28
.ma
y
30
.ma
y
01
.ju
n
03
.ju
n
05
.ju
n
07
.ju
n
09
.ju
n
11
.ju
n
13
.ju
n
15
.ju
n
17
.ju
n
19
.ju
n
21
.ju
n
23
.ju
n
25
.ju
n
27
.ju
n
29
.ju
n
01
.ju
l
03
.ju
l
05
.ju
l
07
.ju
l
09
.ju
l
11
.ju
l
13
.ju
l
15
.ju
l
17
.ju
l
19
.ju
l
21
.ju
l
23
.ju
l
25
.ju
l
27
.ju
l
29
.ju
l
31
.ju
2.a
ug
4.a
ug
6.a
ug
Source: https://www.nj.com/coronavirus/2020/03/see-the-spread-of-nj-coronavirus-in-charts-map-sunday-march-22-2020.html
25 July – 513 cases
31 July – 690 cases
The biggest increase since June 10
Confidential Hovione © 2020August 2020 36
Covid-19 Projections Using Machine Learning – New Jersey - Cases
Source: https://covid19-projections.com/us-nj
Confidential Hovione © 2020August 2020 37
Covid-19 Projections Using Machine Learning – New Jersey - Deaths
Source: https://covid19-projections.com/us-nj
Confidential Hovione © 2020August 2020 38
Highest levels of infection, global and US
Confidential Hovione © 2020August 2020 39
New daily infections per 1 million people
Confidential Hovione © 2020August 2020 40
US new daily infections, current hospitalizations and daily deaths, 7 day avg
Confidential Hovione © 2020August 2020 41
US: 24 largest states: reopening dates, infections and hospitalizations
Sourc
e:
JP
Morg
an
Confidential Hovione © 2020August 2020 42
US: 24 largest states: reopening dates, infections and hospitalizations
Sourc
e:
JP
Morg
an
Recent News
Confidential Hovione © 2020August 2020 44
• 6 August
• Moderna has priced smaller volume agreements for its potential Covid-19 vaccine at between $32 and $37 per dose. Larger volume agreements for the vaccine will be priced lower, the
company said. The vaccine candidate is currently in a Phase III trial, which is designed to enrol approximately 30,000 participants.
• The NIH launched a phase 3 trial of Gilead Sciences' antiviral remdesivir and Merck KGaA's interferon-based multiple sclerosis drug Rebif. The ACTT 3 trial aims to enroll more than 1,000
adults hospitalized with COVID-19 and test a combination of the two drugs against remdesivir alone. The idea is that Rebif—which dampens MS flares by modulating the immune system—
may work alongside remdesivir to help patients recover more quickly.
• 5 August
• Moderna's experimental vaccine protected mice who were exposed to the novel coronavirus, the National Institutes of Health reports.
• Taiwan has granted provisional authorisation to steroid drug dexamethasone as a treatment for Covid-19. The decision comes as the country faces a shortfall of the antiviral drug remdesivir,
according to Reuters. Taiwan had ordered for 2,000 doses of remdesivir to arrive by the end of July, but currently only has 78 doses in stock, which were enough to treat 54 seriously-ill
patients.
• As leading COVID-19 vaccine players advance their programs, pricing is becoming clearer, the Wall Street Journal reports. AstraZeneca has a deal with the U.S. for $4 per dose, while J&J's
Wednesday agreement is for $10 per dose. Pfizer's U.S. agreement is for $19.50 per dose, while Moderna said it'd charge a much higher price.
• 4 August
• A bipartisan coalition of 30 state AGs demanded that U.S. health agencies crack open the market for Gilead Sciences' remdesivir, the only antiviral proven to work against Sars-CoV-2. The
government should exercise its "march-in rights" under the Bayh-Dole Act to allow generic versions of the Gilead drug, which is priced at $250 per vial, the letter argued.
• In Gilead Sciences' portfolio is a drug, GS-441524, that some cat owners buy on the black market to treat feline infectious peritonitis, or FIP. It's also related to the coronavirus drug
remdesivir—and its patent expires first. In a letter to the company and four U.S. agencies, Public Citizen urged Gilead to study GS-441524 in humans for COVID-19, saying the treatment, if
effective, could be a lower-cost alternative to remdesivir. And it might actually be easier to convert to inhaled or oral form, the organization argued.
• 3 August
• A trio of rival drugmakers kicked off a joint study of three drugs that could combat the extreme immune response seen in severe coronavirus patients. The trial will test Amgen's psoriasis
drug Otezla, Takeda's anti-inflammatory Firazyr and AbbVie's HIV hopeful cenicriviroc, each in combination with Gilead Sciences' remdesivir and the low-cost steroid dexamethasone. Early
results could be ready in six weeks, the research alliance said.
The latest coronavirus updates and developments impacting the global
pharmaceutical supply chain…
Confidential Hovione © 2020August 2020 45
• 30 July
• Gilead Sciences aims to produce more than two million doses of its Covid-19 drug remdesivir by the end of the year, according to Bloomberg. In its earnings report, the company said that it
has donated its existing stock of 1.5 million doses of the drug. Gilead expects to make several million more courses in 2021.
• A powdered formulation of Gilead Sciences' remdesivir could prove more potent and easier to administer, thanks to researchers at the University of Texas at Austin who have used their
novel thin-film-freezing technology to create an inhaled form of the antiviral COVID-19 treatment. Remdesivir is currently given to patients via IV; by developing an inhaled version, the
antiviral might reach more patients, prevent contact between infected individuals and health care workers, and lessen symptoms before they become potentially fatal, the research team said.
• 29 July
• Developed nations making advance purchase deals for Pfizer's mRNA-based coronavirus vaccine should expect to pay no less than the $19.50-per-dose price tag set under the drugmaker's
recent U.S. supply pact, CEO Albert Bourla said. The full two-dose course will run for $39 in the U.S.
• The E.U. handed over €63 million ($74 million) to Gilead Sciences for enough doses of its antiviral remdesivir to treat 30,000 COVID-19 patients. The initial supply deal will satisfy "immediate
needs," the European Commission said, adding that it hopes to secure more doses in October.
• Meanwhile, hospitals in U.S. regions hard-hit by COVID-19 reported widespread shortages of Gilead's remdesivir. While the U.S. government started sending out remdesivir shipments after
trials confirmed its benefit in COVID-19, doctors have blasted its distribution model; overwhelmed hospitals have missed out on deliveries while clinics in regions with lower case counts
received ample supply.
• 28 July
• Moderna's 2020 delivery of a safe and effective coronavirus vaccine is a "stretch goal," National Institutes of Health director Francis Collins said, "but it's the right goal for the American
people." Meanwhile, NIAID director Anthony Fauci said trial results could arrive by November, December or possibly even earlier—plus, Fauci is confident in the shot's safety after reviewing
early trial data.
• But Moderna would do well to keep quiet about its trial results timeline, CNBC's Jim Cramer said. By pinning down late-stage readouts to the early fall, the Massachusetts-based biotech
could affect political decisions about stimulus packages and other measures, Cramer said. Meanwhile, Moderna execs' stock sales could portray the company in a negative light given its
massive backing from the U.S. government.
• 27 July
• Moderna kicked off its phase 3 coronavirus vaccine study across 89 U.S. clinical research sites Monday, with results expected as early as November, government and health officials said.
Patients will receive two doses of the mRNA-based shot about four weeks apart, with researchers comparing immune response between the vaccine and placebo arms two weeks after the
second dose.
• The Biomedical Advanced Research and Development Authority (BARDA) upgraded its contract with Moderna, pledging an extra $472 million to support late-stage shot development and
fund the drugmaker's 30,000-patient phase 3 vaccine trial—set to begin Tuesday, the company said. Moderna previously snagged $483 million from BARDA to support development of its
mRNA-based coronavirus vaccine
The latest coronavirus updates and developments impacting the global
pharmaceutical supply chain… (cont.)
Confidential Hovione © 2020August 2020 46
• 23 July
• It may take multiple doses of an approved COVID-19 vaccine to grant immunity, Bill Gates said Wednesday, which could require over 7 billion vaccinations globally. Moderna's frontrunner
shot will require two doses a month apart, and at Tuesday's Congressional hearing, AstraZeneca R&D executive Mene Pangalos said the drugmaker was eyeing multiple doses for its
University of Oxford-partnered candidate, too.
• Pfizer and BioNTech's $1.95 billion deal to supply 100 million vaccine doses to the U.S. drew ire from watchdogs, who warned that the move could lead to price-gouging later. The agreement
includes an option for 500 million more doses at an as-yet-undetermined price. AstraZeneca and Johnson & Johnson both pledged to sell vaccines at no profit to the U.S.—which has shelled
out funding for development in both cases—while Pfizer has expressed interest in making at least a marginal return on its shot.
• Sinopharm's COVID-19 vaccine candidate could roll out for public use by the end of the year, China reported Wednesday. In June, the state-owned firm delayed its expectations for an
approved shot until 2021, citing a lack of trial participants at home. Since then, Sinopharm launched a 15,000-person phase 3 in the United Arab Emirates. Late-stage trials are set to wrap in
about three months, Sinopharm chairman Liu Jingzhen said.
• 22 July
• The University of Oxford's AstraZeneca-partnered COVID-19 vaccine could grant lasting immunity to the virus, but patients will likely need two initial doses and one to two annual boosters
after that, Vaccitech CEO Bill Enright told FiercePharma.
• Brazil aims to lock down doses of Moderna's mRNA vaccine hopeful, and talks with the U.S. biotech are already underway, the country’s interim Health Minister Eduardo Pazuello said. Brazil
has another deal in place to secure 30 million doses of AstraZeneca and the University of Oxford's shot.
• Japan's health ministry gave low-cost steroid dexamethasone the OK for use in COVID-19 patients. The drug, first shown to slash death rates in hospitalized COVID-19 patients in a widely-
publicized U.K. trial, joins Gilead Sciences' remdesivir as the second treatment approved by Japan against COVID-19.
• 20 July
• AstraZeneca and the University of Oxford's COVID-19 vaccine candidate spurred a strong immune response in a phase 1 trial that enrolled over 1,000 patients, data published Monday in the
Lancet showed.
• Mylan launched its generic form of Gilead Sciences' remdesivir in India Monday, marketed under the name Desrem. The drug is approved to treat COVID-19 in adults and children
hospitalized with severe symptoms. Indian drugmakers Cipla and Hetero Drugs have also launched licensed versions of Gilead's antiviral in the country.
• 17 July
• The European Union is hashing out advance purchase deals for COVID-19 vaccines with Moderna, Sanofi, Johnson & Johnson, CureVac and BioNTech, two E.U. sources told Reuters. The
news comes on the heels of a deal in June between four European nations and AstraZeneca to secure 400 million doses of the drugmaker's vaccine hopeful. The E.U. is reportedly furthest
along in talks with J&J, already working out dose counts. Meanwhile, Sanofi, with the aid of GlaxoSmithKline, aims to provide the bloc with 300 million doses of its shot in the second half of
2021.
The latest coronavirus updates and developments impacting the global
pharmaceutical supply chain… (cont.)
Confidential Hovione © 2020August 2020 47
• 16 July
• Executives and directors from Moderna have sold about $171 million in shares since the start of the year, CNBC reported, far outstripping other companies involved in researching COVID-19
drugs and vaccines.
• With phase 1 data on Moderna's mRNA vaccine candidate now available, UBS analyst Navin Jacob thinks Pfizer and BioNTech's rival mRNA shot could still be competitive: While Moderna's
shot proved most effective at the 100mcg dose, BioNTech's vaccine performed well at 10-35% of that dose. Paired with Pfizer's vaccine manufacturing brawn, the partners' shot has a better
chance at meeting global demand, Jacob figures.
• 15 July
• Moderna's mRNA vaccine candidate triggered "robust" levels of neutralizing antibodies in coronavirus patients, newly published phase 1 data show, but some side effects showed up, too.
Forty-five patients were given two injections of the vaccine—at three different dose levels—two weeks apart, with those on the 100 microgram dose yielding the highest antibody count when
compared against a control group of 38 people who recovered from the disease. Now, Moderna is ramping up for a 30,000-participant, phase 3 trial later this month, with plans to recruit
participants from the U.S. states hardest hit by the virus.
• A $99 million federal investment breathed new life into remdesivir early on in the pandemic, but taxpayers are being repaid with "price gouging," Rep. Lloyd Doggett said in a Wall Street
Journal op-ed. Last month, Gilead set its price for remdesivir at $520 per vial, or $3,120 for a five-day course, in a move that the president of cost watchdog group ICER called "responsible."
While Gilead also revealed a lower price for the full course under certain government programs, Doggett has called that initiative "misleading," as it excludes patients on Medicare, Medicaid,
private insurance and those who are uninsured.
• 13 July
• Jefferies analysts pegged Moderna's coronavirus vaccine candidate for a likely approval early next year and figure it could rake in billions in sales, too. The analysts predict 50 million people
will get the vaccine in 2021 at $50 per dose, netting Moderna about $2 billion in 2021 and $5 billion over the next few years. But if the shot doesn't work, the company's stock would be "hit
hard," they warned. Moderna's mRNA-based candidate is slated to enter phase 3 testing this month.
• Swiss contract manufacturer Lonza said Monday that it had licensed its gene expression system to China's Junshi Biosciences to produce its neutralizing COVID-19 antibody, JS016, which
entered an early-stage safety trial in June. Junshi is co-developing its antibody candidate with Eli Lilly and will head up clinical testing in China while Lilly tackles trial work elsewhere. Warp
Speed finalist Moderna tapped Lonza in May for a 10-year manufacturing agreement to churn out doses of its mRNA vaccine candidate.
• Analysts and health officials continued questioning Gilead Sciences' decision to release data on remdesivir Friday that compared clinical trial data with a historical, standard-of-care patient
cohort. Former FDA commissioner Scott Gottlieb called the results encouraging but said they "[need] to be confirmed in a prospective trial." Meanwhile, Raymond James analyst Steven
Seedhouse said, "The aggregate clinical data still pretty clearly point to an inconclusive impact on survival at best.”
• 10 July
• Gilead Sciences released new data Friday showing its antiviral remdesivir slashed death rates by 62% compared with standard treatment, but health experts aren't convinced. Gilead
compared 312 patients dosed with remdesivir in its phase 3 SIMPLE trial against a historical cohort of 818 patients with similar disease severity on "standard of care," but because that
comparison wasn't performed in a controlled trial, the numbers are "deeply flawed," one expert said. Gilead itself said the findings "[require] confirmation in prospective clinical trials."
The latest coronavirus updates and developments impacting the global
pharmaceutical supply chain… (cont.)
Confidential Hovione © 2020August 2020 48
• 9 July
• Officials from Merck, Moderna, Pfizer, AstraZeneca and Johnson & Johnson plan to testify before the House's Oversight and Investigation Subcommittee on July 21 to discuss their progress
on a COVID-19 vaccine. The companies are also expected to share info on upcoming plans to market and distribute those shots should they pass muster in the clinic.
• Moderna tapped contract manufacturer Laboratorios Farmacéuticos Rovi to complete fill-finish work on its mRNA vaccine candidate. Rovi will carry out the work at its Madrid, Spain, facility,
and plans to ramp up a new production line and buy new equipment to help Moderna meet its goal to churn out hundreds of millions of shot doses for deployment outside of the U.S. by early
2021. Rovi will also recruit additional staff to meet the new manufacturing demand.
• Gilead Sciences dosed the first patients in a phase 1a trial studying an inhaled formulation of remdesivir for early stage COVID-19. The drugmaker aims to recruit about 60 U.S. patients aged
18 to 45 for the trial, which will compare a nebulized version with placebo. Delivering remdesivir straight to the lungs could cut the risk of side effects and expand its use to outpatients, Gilead
said; remdesivir is currently given to hospital patients intravenously.
• Gilead plans to boost worldwide production of remdesivir to supply the antiviral in Europe based on each country's rate of infection, the company's German managing director Bettina Bauer
said. Talks are already underway with the German government, Bauer told German business magazine WirtschaftsWoche. The drugmaker aims to ramp up its monthly supply from 190,000
treatment cycles to 2 million by December, she said.
• Indian drugmaker Cipla has deployed its version of remdesivir in the country, setting the sticker price at INR 4,000 per 100mg vial, or about $53.38—one of the lowest prices globally. For
comparison, Mylan has capped its generic form of the drug at INR 4,800 ($64.05) per 100mg vial, while Hetero set a maximum retail price of INR 5,400 ($72.06). Cipla aims to dispense
80,000 vials in the first month, and will make them available through government and hospital channels, CEO Nikhil Chopra said.
• 8 July
• Cipla announced that its version of remdesivir is slated to hit Indian markets in the next few days. Cipla partnered with Mumbai-based BDR Pharma to manufacture the drug, which in turn
sub-contracted Sovereign Pharma to complete fill-finish work. The partners haven't said how much they plan to ship, but Sovereign said it can scale up to 95,000 vials per month.
• 7 July
• Moderna's shares dropped 5% last week when news surfaced that it might delay the launch of its phase 3 vaccine trial due to protocol changes. Now, some of those potential hiccups have
come to light: Moderna sparred with government experts over how to run its trial, sought a lower bar for approval than the 50% efficacy rate outlined by the FDA, and submitted trial protocols
late, three sources close to the vaccine project told Reuters. Moderna has dismissed the snags as "differences of opinion."
• 6 July
• The European Commission granted a conditional OK for Gilead's remdesivir to treat COVID-19 patients 12 years and older with pneumonia requiring oxygen support. The conditional
approval is good for one year, but the commission may extend it if the drug shows promise in trials testing it in younger patients and in earlier stages of the disease.
The latest coronavirus updates and developments impacting the global
pharmaceutical supply chain… (cont.)
Confidential Hovione © 2020August 2020 65
• https://en.wikipedia.org/wiki/Timeline_of_the_2019%E2%80%9320_Wuhan_coronavirus_outbreak
• https://www.seattletimes.com/seattle-news/health/coronavirus-timeline-how-the-outbreak-unfolded/
• https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
• https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
• https://www.pharmaceutical-technology.com/news/coronavirus-a-timeline-of-how-the-deadly-outbreak-evolved/
• https://www.cphi-online.com/updated-covid19-pharma-tracker-news082415.html
• https://www.dgs.pt/em-destaque.aspx
Sources